Literature DB >> 10641985

Duration of penicillin prophylaxis in sickle cell anemia: issues and controversies.

V B Pai1, M C Nahata.   

Abstract

Functional asplenia occurs in 94% of patients with homozygous sickle cell anemia by 5 years of age and may result in fatal septicemia due to encapsulated microorganisms such as Streptococcus pneumoniae. Penicillin prophylaxis in these patients significantly reduces the risk of septicemia; however, continuation of prophylaxis beyond 5 years of age is controversial, since the risk of developing septicemia is reduced after this age and prolonged prophylaxis may lead to emergence of penicillin resistance. Although reports of penicillin-resistant pneumococci in patients receiving penicillin prophylaxis are conflicting, the prevalence of these organisms in the general population in North America increased from 5% in 1989 to more than 35% in 1997. Discontinuation of prophylaxis after age 5 years may be recommended because of lack of benefit, difficulty maintaining compliance, reduced risk of developing pneumococcal bacteremia after that age, and increase in prevalence of penicillin-resistant pneumococci worldwide.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10641985     DOI: 10.1592/phco.20.1.110.34660

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  7 in total

1.  Pharmacological management of sickle cell disease.

Authors:  Uche Anadu Ndefo; Angie Eaton Maxwell; Huong Nguyen; Tochukwu L Chiobi
Journal:  P T       Date:  2008-04

2.  Penicillin prophylaxis in children with sickle cell disease.

Authors:  Mary Petrea Cober; Stephanie J Phelps
Journal:  J Pediatr Pharmacol Ther       Date:  2010-07

Review 3.  Sickle cell disease.

Authors:  Martin M Meremikwu; Uduak Okomo
Journal:  BMJ Clin Evid       Date:  2016-01-22

Review 4.  Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease.

Authors:  Angela E Rankine-Mullings; Shirley Owusu-Ofori
Journal:  Cochrane Database Syst Rev       Date:  2017-10-10

5.  Pediatric Sickle Cell Disease in Sudan: Complications and Management.

Authors:  Meysaa Talha; Bashier Osman; Safa Abdalla; Hind Mirghani; Iman Abdoon
Journal:  Anemia       Date:  2022-02-14

Review 6.  Current modalities of sickle cell disease management.

Authors:  Adekunle Sanyaolu; Ejoke Agiri; Carl Bertram; Latasha Brookes; Jesy Choudhury; Dorina Datt; Amira Ibrahim; Anna Maciejko; Anna Mansfield; Jasmine Nkrumah; Martina Williams
Journal:  Blood Sci       Date:  2020-08-27

7.  Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease.

Authors:  Angela E Rankine-Mullings; Shirley Owusu-Ofori
Journal:  Cochrane Database Syst Rev       Date:  2021-03-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.